Skip to main content

Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation

2008-07-16

During the administration of advanced cardiac life support for resuscitation from cardiac arrest, a combination of vasopressin and epinephrine may be more effective than epinephrine or vasopressin alone, but evidence is insufficient to make clinical recommendations.


Other Awareness Article

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

2008-07-16

Background: Increased concentrations of low density lipoprotein cholesterol (LDL-C), as well as of small dense LDL-C (sdLDL-C), are considered as cardiovascular risk factors.


Other Awareness Article

Combination Endoscopic and Drug Therapy to Prevent Variceal Rebleeding in Cirrhosis

2008-07-16

Background: Combining endoscopic therapy and β-blockers may improve outcomes in patients with cirrhosis and bleeding esophageal varices.

Purpose: To assess whether a combination of endoscopic and drug therapy prevents overall and variceal rebleeding and improves survival better than either therapy alone.


Other Awareness Article

Metformin versus Insulin for the Treatment of Gestational Diabetes

2008-07-16

Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking.


Other Awareness Article

Fluoroquinolones: Boxed Warning to be added for risk of tendon rupture and tendinitis

2008-07-21

The U.S. Food and Drug Administration, the american counterpart to the Saudi Food and Drug Authority (SFDA), notified healthcare professionals that a BOXED WARNING and Medication Guide are to be added to the prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use.


Other Awareness Article

Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate

2008-07-21

Objectives: Everolimus, a proliferation signal inhibitor with disease-modifying properties, may be useful in treating rheumatoid arthritis (RA). This proof-of-concept study assessed efficacy and safety of everolimus in combination with methotrexate (MTX) in patients with refractory RA.


Other Awareness Article

Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis

2008-07-29

Objective : To examine the effects of extended release tramadol (tramadol ER) on reducing pain-related sleep disturbances (PRSDs) in patients (20 – 80 years) with moderate to moderately severe pain with radiographically confirmed osteoarthritis (OA) of the knee or hip.


Other Awareness Article

Sildenafil Treatment of Women With Antidepressant-Associated Sexual Dysfunction

2008-07-31

Context Antidepressant-associated sexual dysfunction is a common adverse effect that frequently results in premature medication treatment discontinuation and for which no treatment has demonstrated efficacy in women.

Objective To evaluate the efficacy of sildenafil for sexual dysfunction associated with selective and nonselective serotonin reuptake inhibitors (SRIs) in women.


Other Awareness Article

The cardiovascular safety of rosiglitazone

2008-08-10

Background : Thiazolidinediones (rosiglitazone, pioglitazone) influence insulin sensitivity and are used for the treatment of Type 2 diabetes. Rosiglitazone achieves sustained improvements in glycaemic control, whilst having pleiotropic effects on cardiovascular risk factors. However, analysis of cardiovascular outcomes has been controversial.

Objectives: Review the cardiovascular safety of rosiglitazone by conducting a literature search.


Other Awareness Article

Efficacy and tolerability of combination therapy with valsartan/ hydrochlorothiazide in the initial treatment of severe hypertension

2008-08-10

Objective: Most patients with severe hypertension are at high risk for cardiovascular events and require prompt blood pressure (BP)-lowering and combination therapy to achieve BP goals. This study evaluated the therapeutic efficacy and tolerability of initial treatment with the combination of valsartan and hydrochlorothiazide (HCTZ) compared with valsartan monotherapy in patients with severe hypertension.


Other Awareness Article

Subscribe to General health